The Use of Antibiotics After Hospital Discharge in Septic Abortion
Hospital de Clinicas de Porto Alegre
The use of antibiotics in post-partum infection has been abbreviated. After 48 hours of
clinical improvement, the patient is discharged from the hospital without antibiotics. No
trials has been found in cases of septic abortion.
The purpose of the present study is to verify the need of antibiotics after clinical
improvement in cases of septic abortion.
Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network
Agency for Healthcare Research and Quality (AHRQ)
Many women present in primary care with vaginal complaints. The best way of managing these
complaints is unclear. This trial will test two different methods of managing patients with
vaginal complaints. This is a pilot trial.
Induction of Clinical Response Using Rifaximin in Crohn's Disease
Valeant Pharmaceuticals International, Inc.
Antibiotics have been used to treat Crohn's disease symptoms with the best studied
antibiotics being Cipro and Flagyl. Rifaximin is a poorly absorbed oral antibiotic that is
FDA approved for travelers' diarrhea. It works by inhibiting bacterial reproduction. It is
very poorly absorbed and over 97% of the drug taken orally is excreted in the feces.
The purpose of this study is to evaluate the potential benefits and safety of Rifaximin for
the treatment of moderate to severe symptoms of Crohn's Disease.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.